VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo

Elizabeth A Harrington , David Bebbington , Jeff Moore , Richele K Rasmussen , Abi O Ajose-Adeogun , Tomoko Nakayama , Joanne A Graham , Cecile Demur , Thierry Hercend , Anita Diu-Hercend , Michael Su , Julian M C Golec & Karen M Miller

To read this article in full you may need to log in, make a payment or gain access through a site license (see right).